.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
Accenture
Cipla
Healthtrust
Dow
Farmers Insurance
Julphar
Boehringer Ingelheim
Colorcon
Covington

Generated: December 18, 2017

DrugPatentWatch Database Preview

MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER Drug Profile

« Back to Dashboard

Which patents cover Mannitol 10% W/ Dextrose 5% In Distilled Water, and when can generic versions of Mannitol 10% W/ Dextrose 5% In Distilled Water launch?

Mannitol 10% W/ Dextrose 5% In Distilled Water is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER is mannitol. There are seventeen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the mannitol profile page.

Summary for MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER

Drug patent expirations by year for MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER

Medical Subject Heading (MeSH) Categories for MANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATER

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B BraunMANNITOL 10% W/ DEXTROSE 5% IN DISTILLED WATERmannitolINJECTABLE;INJECTION016080-006Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Mallinckrodt
Boehringer Ingelheim
Colorcon
Teva
Accenture
Citi
Cipla
Baxter
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot